OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ALKERMES PLC DL-,01/  IE00B56GVS15  /

Frankfurt
5/24/2024  8:10:44 AM Chg. -0.2000 Volume Bid9:59:06 PM Ask9:59:06 PM Market Capitalization Dividend Y. P/E Ratio
21.8000EUR -0.91% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 3.75 bill.EUR - -
GlobeNewswire 3/26 Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Up...
GlobeNewswire 3/6 Zenas BioPharma Appoints Patricia Allen to its Board of Directors
GlobeNewswire 1/18 SediVision Wastewater Technology Announces New Company Vice President
GlobeNewswire 1/8 Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
GlobeNewswire 12/4/2023 Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
GlobeNewswire 11/15/2023 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire 9/26/2023 OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board
GlobeNewswire 9/11/2023 Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
GlobeNewswire 8/29/2023 Arbor Biotechnologies Appoints Ajim Tamboli as Chief Financial Officer
GlobeNewswire 3/28/2022 Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business...
GlobeNewswire 3/16/2022 Baudax Bio Reports 2021 Fourth Quarter and Annual Financial Results
Newsfile Corp 3/15/2022 Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development
GlobeNewswire 3/15/2022 Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 3/8/2022 Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surg...
GlobeNewswire 3/2/2022 Baudax Bio Announces Seventh Orange Book Listable Patent for ANJESO®
GlobeNewswire 2/10/2022 Finch Therapeutics Announces Additions to Senior Leadership Team
GlobeNewswire 1/24/2022 Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates
GlobeNewswire 12/6/2021 AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors
GlobeNewswire 11/22/2021 Zai Lab Appoints Richard Gaynor, MD, to its Board of Directors
GlobeNewswire 11/4/2021 Baudax Bio Reports Third Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 9/8/2021 Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer
GlobeNewswire 8/5/2021 Baudax Bio Reports Second Quarter 2021 Financial Results and Highlights
GlobeNewswire 6/22/2021 BioCorRx Welcomes Four Experts to Expanded Scientific Advisory Board
GlobeNewswire 6/8/2021 Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on th...
GlobeNewswire 5/17/2021 Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal Pain Management